SOURCE-LINKED STUDY SUMMARY
The Impact of Common Medications on Male Fertility: An Updated Systematic Review.
Abstract summarizedQuality not appraised
- What was studied
- An updated systematic review of commonly used medicines and male reproductive outcomes.
- Who / model studied
- 184 original studies published from 2016 to 2025, involving human males exposed to noncytotoxic medicines. Outcomes included sperm production, semen measurements and reproductive hormones.
- Studied dose & schedule
- Dose and schedule were not reported in the source used for this summary.
- What the study found
- The authors describe adverse hormone or fertility findings for medicines including testosterone, anabolic steroids and opioids, and highlight newer evidence involving drugs such as duloxetine, dutasteride and valproate.
- Limitations & context
- Findings were summarized descriptively across different drug classes. The abstract provides no drug-specific risk estimates, doses or reversibility data, so it cannot predict an individual's fertility outcome.
Read summary source ↗ · Prepared 9/15/2026 · AI-assisted, source-based summary
Review record & corrections
Summary prepared: . Source scope: abstract. This is an AI-assisted source summary, not an independent clinician sign-off.
No public field-by-field revision history is available for this card yet. The date above is the summary date, not proof that every field was updated then.
Inspect the source · Correction policyResearch findings apply to the population and conditions studied. This educational summary is not a treatment recommendation or a formal assessment of study quality.
Original publication ↗ · DOI: 10.1111/andr.70381